Global and United States Non-opioid Pain Patch Market Report & Forecast 2024-2031

Report ID: 1836211 | Published Date: Jan 2025 | No. of Page: 119 | Base Year: 2024 | Rating: 4 | Webstory: Check our Web story
1 Study Coverage
    1.1 Non-opioid Pain Patch Product Introduction
    1.2 Global Non-opioid Pain Patch Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Non-opioid Pain Patch Sales in US$ Million for the Year 2017-2028
        1.2.2 Global Non-opioid Pain Patch Sales in Volume for the Year 2017-2028
    1.3 United States Non-opioid Pain Patch Outlook 2017 VS 2022 VS 2028
        1.3.1 United States Non-opioid Pain Patch Sales in US$ Million for the Year 2017-2028
        1.3.2 United States Non-opioid Pain Patch Sales in Volume for the Year 2017-2028
    1.4 Non-opioid Pain Patch Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.4.1 The Market Share of United States Non-opioid Pain Patch in Global, 2017 VS 2022 VS 2028
        1.4.2 The Growth Rate of Non-opioid Pain Patch Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.5 Non-opioid Pain Patch Market Dynamics
        1.5.1 Non-opioid Pain Patch Industry Trends
        1.5.2 Non-opioid Pain Patch Market Drivers
        1.5.3 Non-opioid Pain Patch Market Challenges
        1.5.4 Non-opioid Pain Patch Market Restraints
    1.6 Study Objectives
    1.7 Years Considered
2 Market by Type
    2.1 Non-opioid Pain Patch Market Segment by Type
        2.1.1 Lidocaine Patches
        2.1.2 Diclofenac Patches
        2.1.3 Indomethacin Patches
        2.1.4 Counter-Irritant Patches
        2.1.5 Fentanyl Patches
        2.1.6 Others
    2.2 Global Non-opioid Pain Patch Market Size by Type
        2.2.1 Global Non-opioid Pain Patch Sales in Value, by Type (2017, 2022 & 2028)
        2.2.2 Global Non-opioid Pain Patch Sales in Volume, by Type (2017, 2022 & 2028)
        2.2.3 Global Non-opioid Pain Patch Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    2.3 United States Non-opioid Pain Patch Market Size by Type
        2.3.1 United States Non-opioid Pain Patch Sales in Value, by Type (2017, 2022 & 2028)
        2.3.2 United States Non-opioid Pain Patch Sales in Volume, by Type (2017, 2022 & 2028)
        2.3.3 United States Non-opioid Pain Patch Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
    3.1 Non-opioid Pain Patch Market Segment by Application
        3.1.1 OTC
        3.1.2 Rx
    3.2 Global Non-opioid Pain Patch Market Size by Application
        3.2.1 Global Non-opioid Pain Patch Sales in Value, by Application (2017, 2022 & 2028)
        3.2.2 Global Non-opioid Pain Patch Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 Global Non-opioid Pain Patch Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    3.3 United States Non-opioid Pain Patch Market Size by Application
        3.3.1 United States Non-opioid Pain Patch Sales in Value, by Application (2017, 2022 & 2028)
        3.3.2 United States Non-opioid Pain Patch Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 United States Non-opioid Pain Patch Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Non-opioid Pain Patch Competitor Landscape by Company
    4.1 Global Non-opioid Pain Patch Market Size by Company
        4.1.1 Top Global Non-opioid Pain Patch Manufacturers Ranked by Revenue (2021)
        4.1.2 Global Non-opioid Pain Patch Revenue by Manufacturer (2017-2022)
        4.1.3 Global Non-opioid Pain Patch Sales by Manufacturer (2017-2022)
        4.1.4 Global Non-opioid Pain Patch Price by Manufacturer (2017-2022)
    4.2 Global Non-opioid Pain Patch Concentration Ratio (CR)
        4.2.1 Non-opioid Pain Patch Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Non-opioid Pain Patch in 2021
        4.2.3 Global Non-opioid Pain Patch Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Non-opioid Pain Patch Manufacturing Base Distribution, Product Type
        4.3.1 Global Non-opioid Pain Patch Manufacturers, Headquarters and Distribution of Producing Region
        4.3.2 Manufacturers Non-opioid Pain Patch Product Type
        4.3.3 Date of International Manufacturers Enter into Non-opioid Pain Patch Market
    4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    4.5 United States Non-opioid Pain Patch Market Size by Company
        4.5.1 Top Non-opioid Pain Patch Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Non-opioid Pain Patch Revenue by Players (2020, 2021 & 2022)
        4.5.3 United States Non-opioid Pain Patch Sales by Players (2020, 2021 & 2022)
5 Global Non-opioid Pain Patch Market Size by Region
    5.1 Global Non-opioid Pain Patch Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Non-opioid Pain Patch Market Size in Volume by Region (2017-2028)
        5.2.1 Global Non-opioid Pain Patch Sales in Volume by Region: 2017-2022
        5.2.2 Global Non-opioid Pain Patch Sales in Volume Forecast by Region (2023-2028)
    5.3 Global Non-opioid Pain Patch Market Size in Value by Region (2017-2028)
        5.3.1 Global Non-opioid Pain Patch Sales in Value by Region: 2017-2022
        5.3.2 Global Non-opioid Pain Patch Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Non-opioid Pain Patch Market Size YoY Growth 2017-2028
        6.1.2 North America Non-opioid Pain Patch Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Non-opioid Pain Patch Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Non-opioid Pain Patch Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Non-opioid Pain Patch Market Size YoY Growth 2017-2028
        6.3.2 Europe Non-opioid Pain Patch Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Non-opioid Pain Patch Market Size YoY Growth 2017-2028
        6.4.2 Latin America Non-opioid Pain Patch Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Non-opioid Pain Patch Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Non-opioid Pain Patch Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 UAE
7 Company Profiles
    7.1 Hisamitsu
        7.1.1 Hisamitsu Corporation Information
        7.1.2 Hisamitsu Description and Business Overview
        7.1.3 Hisamitsu Non-opioid Pain Patch Sales, Revenue and Gross Margin (2017-2022)
        7.1.4 Hisamitsu Non-opioid Pain Patch Products Offered
        7.1.5 Hisamitsu Recent Development
    7.2 Mylan
        7.2.1 Mylan Corporation Information
        7.2.2 Mylan Description and Business Overview
        7.2.3 Mylan Non-opioid Pain Patch Sales, Revenue and Gross Margin (2017-2022)
        7.2.4 Mylan Non-opioid Pain Patch Products Offered
        7.2.5 Mylan Recent Development
    7.3 Johnson & Johnson
        7.3.1 Johnson & Johnson Corporation Information
        7.3.2 Johnson & Johnson Description and Business Overview
        7.3.3 Johnson & Johnson Non-opioid Pain Patch Sales, Revenue and Gross Margin (2017-2022)
        7.3.4 Johnson & Johnson Non-opioid Pain Patch Products Offered
        7.3.5 Johnson & Johnson Recent Development
    7.4 Actavis
        7.4.1 Actavis Corporation Information
        7.4.2 Actavis Description and Business Overview
        7.4.3 Actavis Non-opioid Pain Patch Sales, Revenue and Gross Margin (2017-2022)
        7.4.4 Actavis Non-opioid Pain Patch Products Offered
        7.4.5 Actavis Recent Development
    7.5 Lingrui
        7.5.1 Lingrui Corporation Information
        7.5.2 Lingrui Description and Business Overview
        7.5.3 Lingrui Non-opioid Pain Patch Sales, Revenue and Gross Margin (2017-2022)
        7.5.4 Lingrui Non-opioid Pain Patch Products Offered
        7.5.5 Lingrui Recent Development
    7.6 Teikoku Seiyaku
        7.6.1 Teikoku Seiyaku Corporation Information
        7.6.2 Teikoku Seiyaku Description and Business Overview
        7.6.3 Teikoku Seiyaku Non-opioid Pain Patch Sales, Revenue and Gross Margin (2017-2022)
        7.6.4 Teikoku Seiyaku Non-opioid Pain Patch Products Offered
        7.6.5 Teikoku Seiyaku Recent Development
    7.7 Sanofi
        7.7.1 Sanofi Corporation Information
        7.7.2 Sanofi Description and Business Overview
        7.7.3 Sanofi Non-opioid Pain Patch Sales, Revenue and Gross Margin (2017-2022)
        7.7.4 Sanofi Non-opioid Pain Patch Products Offered
        7.7.5 Sanofi Recent Development
    7.8 Novartis
        7.8.1 Novartis Corporation Information
        7.8.2 Novartis Description and Business Overview
        7.8.3 Novartis Non-opioid Pain Patch Sales, Revenue and Gross Margin (2017-2022)
        7.8.4 Novartis Non-opioid Pain Patch Products Offered
        7.8.5 Novartis Recent Development
    7.9 Qizheng
        7.9.1 Qizheng Corporation Information
        7.9.2 Qizheng Description and Business Overview
        7.9.3 Qizheng Non-opioid Pain Patch Sales, Revenue and Gross Margin (2017-2022)
        7.9.4 Qizheng Non-opioid Pain Patch Products Offered
        7.9.5 Qizheng Recent Development
    7.10 Endo
        7.10.1 Endo Corporation Information
        7.10.2 Endo Description and Business Overview
        7.10.3 Endo Non-opioid Pain Patch Sales, Revenue and Gross Margin (2017-2022)
        7.10.4 Endo Non-opioid Pain Patch Products Offered
        7.10.5 Endo Recent Development
    7.11 Huarun 999
        7.11.1 Huarun 999 Corporation Information
        7.11.2 Huarun 999 Description and Business Overview
        7.11.3 Huarun 999 Non-opioid Pain Patch Sales, Revenue and Gross Margin (2017-2022)
        7.11.4 Huarun 999 Non-opioid Pain Patch Products Offered
        7.11.5 Huarun 999 Recent Development
    7.12 GSK
        7.12.1 GSK Corporation Information
        7.12.2 GSK Description and Business Overview
        7.12.3 GSK Non-opioid Pain Patch Sales, Revenue and Gross Margin (2017-2022)
        7.12.4 GSK Products Offered
        7.12.5 GSK Recent Development
    7.13 Haw Par
        7.13.1 Haw Par Corporation Information
        7.13.2 Haw Par Description and Business Overview
        7.13.3 Haw Par Non-opioid Pain Patch Sales, Revenue and Gross Margin (2017-2022)
        7.13.4 Haw Par Products Offered
        7.13.5 Haw Par Recent Development
    7.14 Nichiban
        7.14.1 Nichiban Corporation Information
        7.14.2 Nichiban Description and Business Overview
        7.14.3 Nichiban Non-opioid Pain Patch Sales, Revenue and Gross Margin (2017-2022)
        7.14.4 Nichiban Products Offered
        7.14.5 Nichiban Recent Development
    7.15 Mentholatum
        7.15.1 Mentholatum Corporation Information
        7.15.2 Mentholatum Description and Business Overview
        7.15.3 Mentholatum Non-opioid Pain Patch Sales, Revenue and Gross Margin (2017-2022)
        7.15.4 Mentholatum Products Offered
        7.15.5 Mentholatum Recent Development
    7.16 Laboratoires Genevrier
        7.16.1 Laboratoires Genevrier Corporation Information
        7.16.2 Laboratoires Genevrier Description and Business Overview
        7.16.3 Laboratoires Genevrier Non-opioid Pain Patch Sales, Revenue and Gross Margin (2017-2022)
        7.16.4 Laboratoires Genevrier Products Offered
        7.16.5 Laboratoires Genevrier Recent Development
    7.17 BLUE-EMU
        7.17.1 BLUE-EMU Corporation Information
        7.17.2 BLUE-EMU Description and Business Overview
        7.17.3 BLUE-EMU Non-opioid Pain Patch Sales, Revenue and Gross Margin (2017-2022)
        7.17.4 BLUE-EMU Products Offered
        7.17.5 BLUE-EMU Recent Development
8 Industry Chain and Sales Channels Analysis
    8.1 Non-opioid Pain Patch Industry Chain Analysis
    8.2 Non-opioid Pain Patch Key Raw Materials
        8.2.1 Key Raw Materials
        8.2.2 Non-opioid Pain Patch Distributors
    8.3 Non-opioid Pain Patch Production Mode & Process
    8.4 Non-opioid Pain Patch Sales and Marketing
        8.4.1 Non-opioid Pain Patch Sales Channels
        8.4.2 Non-opioid Pain Patch Distributors
    8.5 Non-opioid Pain Patch Customers
9 Research Findings and Conclusion
10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer
List of Tables
    Table 1. Non-opioid Pain Patch CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Non-opioid Pain Patch Market Trends
    Table 3. Non-opioid Pain Patch Market Drivers
    Table 4. Non-opioid Pain Patch Market Challenges
    Table 5. Non-opioid Pain Patch Market Restraints
    Table 6. Global Non-opioid Pain Patch Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Non-opioid Pain Patch Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Non-opioid Pain Patch Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Non-opioid Pain Patch Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Non-opioid Pain Patch Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Non-opioid Pain Patch Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Non-opioid Pain Patch Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Non-opioid Pain Patch Sales by Manufacturer, (M Units), 2017-2022
    Table 14. Global Non-opioid Pain Patch Sales Share by Manufacturer, 2017-2022
    Table 15. Global Non-opioid Pain Patch Price by Manufacturer (2017-2022) & (USD/K Units)
    Table 16. Global Non-opioid Pain Patch Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Non-opioid Pain Patch by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-opioid Pain Patch as of 2021)
    Table 18. Top Players of Non-opioid Pain Patch in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Non-opioid Pain Patch Product Type
    Table 20. Date of International Manufacturers Enter into Non-opioid Pain Patch Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Non-opioid Pain Patch Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Non-opioid Pain Patch Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Non-opioid Pain Patch Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Non-opioid Pain Patch Sales by Players, (M Units), 2020, 2021 & 2022
    Table 26. United States Non-opioid Pain Patch Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Non-opioid Pain Patch Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Non-opioid Pain Patch Sales in Volume by Region (2017-2022) & (M Units)
    Table 29. Global Non-opioid Pain Patch Sales in Volume Forecast by Region (2023-2028) & (M Units)
    Table 30. Global Non-opioid Pain Patch Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Non-opioid Pain Patch Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Non-opioid Pain Patch Sales in Volume by Country (2017-2028) & (M Units)
    Table 33. North America Non-opioid Pain Patch Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Non-opioid Pain Patch Sales in Volume by Region (2017-2028) & (M Units)
    Table 35. Asia Pacific Non-opioid Pain Patch Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Non-opioid Pain Patch Sales in Volume by Country (2017-2028) & (M Units)
    Table 37. Europe Non-opioid Pain Patch Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Non-opioid Pain Patch Sales in Volume by Country (2017-2028) & (M Units)
    Table 39. Latin Americaa Non-opioid Pain Patch Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Non-opioid Pain Patch Sales in Volume by Country (2017-2028) & (M Units)
    Table 41. Middle East and Africa Non-opioid Pain Patch Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Hisamitsu Corporation Information
    Table 43. Hisamitsu Description and Business Overview
    Table 44. Hisamitsu Non-opioid Pain Patch Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2017-2022)
    Table 45. Hisamitsu Non-opioid Pain Patch Product
    Table 46. Hisamitsu Recent Development
    Table 47. Mylan Corporation Information
    Table 48. Mylan Description and Business Overview
    Table 49. Mylan Non-opioid Pain Patch Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2017-2022)
    Table 50. Mylan Product
    Table 51. Mylan Recent Development
    Table 52. Johnson & Johnson Corporation Information
    Table 53. Johnson & Johnson Description and Business Overview
    Table 54. Johnson & Johnson Non-opioid Pain Patch Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2017-2022)
    Table 55. Johnson & Johnson Product
    Table 56. Johnson & Johnson Recent Development
    Table 57. Actavis Corporation Information
    Table 58. Actavis Description and Business Overview
    Table 59. Actavis Non-opioid Pain Patch Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2017-2022)
    Table 60. Actavis Product
    Table 61. Actavis Recent Development
    Table 62. Lingrui Corporation Information
    Table 63. Lingrui Description and Business Overview
    Table 64. Lingrui Non-opioid Pain Patch Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2017-2022)
    Table 65. Lingrui Product
    Table 66. Lingrui Recent Development
    Table 67. Teikoku Seiyaku Corporation Information
    Table 68. Teikoku Seiyaku Description and Business Overview
    Table 69. Teikoku Seiyaku Non-opioid Pain Patch Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2017-2022)
    Table 70. Teikoku Seiyaku Product
    Table 71. Teikoku Seiyaku Recent Development
    Table 72. Sanofi Corporation Information
    Table 73. Sanofi Description and Business Overview
    Table 74. Sanofi Non-opioid Pain Patch Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2017-2022)
    Table 75. Sanofi Product
    Table 76. Sanofi Recent Development
    Table 77. Novartis Corporation Information
    Table 78. Novartis Description and Business Overview
    Table 79. Novartis Non-opioid Pain Patch Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2017-2022)
    Table 80. Novartis Product
    Table 81. Novartis Recent Development
    Table 82. Qizheng Corporation Information
    Table 83. Qizheng Description and Business Overview
    Table 84. Qizheng Non-opioid Pain Patch Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2017-2022)
    Table 85. Qizheng Product
    Table 86. Qizheng Recent Development
    Table 87. Endo Corporation Information
    Table 88. Endo Description and Business Overview
    Table 89. Endo Non-opioid Pain Patch Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2017-2022)
    Table 90. Endo Product
    Table 91. Endo Recent Development
    Table 92. Huarun 999 Corporation Information
    Table 93. Huarun 999 Description and Business Overview
    Table 94. Huarun 999 Non-opioid Pain Patch Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2017-2022)
    Table 95. Huarun 999 Product
    Table 96. Huarun 999 Recent Development
    Table 97. GSK Corporation Information
    Table 98. GSK Description and Business Overview
    Table 99. GSK Non-opioid Pain Patch Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2017-2022)
    Table 100. GSK Product
    Table 101. GSK Recent Development
    Table 102. Haw Par Corporation Information
    Table 103. Haw Par Description and Business Overview
    Table 104. Haw Par Non-opioid Pain Patch Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2017-2022)
    Table 105. Haw Par Product
    Table 106. Haw Par Recent Development
    Table 107. Nichiban Corporation Information
    Table 108. Nichiban Description and Business Overview
    Table 109. Nichiban Non-opioid Pain Patch Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2017-2022)
    Table 110. Nichiban Product
    Table 111. Nichiban Recent Development
    Table 112. Mentholatum Corporation Information
    Table 113. Mentholatum Description and Business Overview
    Table 114. Mentholatum Non-opioid Pain Patch Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2017-2022)
    Table 115. Mentholatum Product
    Table 116. Mentholatum Recent Development
    Table 117. Laboratoires Genevrier Corporation Information
    Table 118. Laboratoires Genevrier Description and Business Overview
    Table 119. Laboratoires Genevrier Non-opioid Pain Patch Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2017-2022)
    Table 120. Laboratoires Genevrier Product
    Table 121. Laboratoires Genevrier Recent Development
    Table 122. BLUE-EMU Corporation Information
    Table 123. BLUE-EMU Description and Business Overview
    Table 124. BLUE-EMU Non-opioid Pain Patch Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2017-2022)
    Table 125. BLUE-EMU Product
    Table 126. BLUE-EMU Recent Development
    Table 127. Key Raw Materials Lists
    Table 128. Raw Materials Key Suppliers Lists
    Table 129. Non-opioid Pain Patch Customers List
    Table 130. Non-opioid Pain Patch Distributors List
    Table 131. Research Programs/Design for This Report
    Table 132. Key Data Information from Secondary Sources
    Table 133. Key Data Information from Primary Sources
List of Figures
    Figure 1. Non-opioid Pain Patch Product Picture
    Figure 2. Global Non-opioid Pain Patch Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Non-opioid Pain Patch Market Size 2017-2028 (US$ Million)
    Figure 4. Global Non-opioid Pain Patch Sales 2017-2028 (M Units)
    Figure 5. United States Non-opioid Pain Patch Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Non-opioid Pain Patch Market Size 2017-2028 (US$ Million)
    Figure 7. United States Non-opioid Pain Patch Sales 2017-2028 (M Units)
    Figure 8. United States Non-opioid Pain Patch Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Non-opioid Pain Patch Market Share in Global, in Volume (M Units) 2017-2028
    Figure 10. Non-opioid Pain Patch Report Years Considered
    Figure 11. Product Picture of Lidocaine Patches
    Figure 12. Product Picture of Diclofenac Patches
    Figure 13. Product Picture of Indomethacin Patches
    Figure 14. Product Picture of Counter-Irritant Patches
    Figure 15. Product Picture of Fentanyl Patches
    Figure 16. Product Picture of Others
    Figure 17. Global Non-opioid Pain Patch Market Share by Type in 2022 & 2028
    Figure 18. Global Non-opioid Pain Patch Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 19. Global Non-opioid Pain Patch Sales Market Share in Value by Type (2017-2028)
    Figure 20. Global Non-opioid Pain Patch Sales by Type (2017-2028) & (M Units)
    Figure 21. Global Non-opioid Pain Patch Sales Market Share in Volume by Type (2017-2028)
    Figure 22. Global Non-opioid Pain Patch Price by Type (2017-2028) & (USD/K Units)
    Figure 23. United States Non-opioid Pain Patch Market Share by Type in 2022 & 2028
    Figure 24. United States Non-opioid Pain Patch Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 25. United States Non-opioid Pain Patch Sales Market Share in Value by Type (2017-2028)
    Figure 26. United States Non-opioid Pain Patch Sales by Type (2017-2028) & (M Units)
    Figure 27. United States Non-opioid Pain Patch Sales Market Share in Volume by Type (2017-2028)
    Figure 28. United States Non-opioid Pain Patch Price by Type (2017-2028) & (USD/K Units)
    Figure 29. Product Picture of OTC
    Figure 30. Product Picture of Rx
    Figure 31. Global Non-opioid Pain Patch Market Share by Application in 2022 & 2028
    Figure 32. Global Non-opioid Pain Patch Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 33. Global Non-opioid Pain Patch Sales Market Share in Value by Application (2017-2028)
    Figure 34. Global Non-opioid Pain Patch Sales by Application (2017-2028) & (M Units)
    Figure 35. Global Non-opioid Pain Patch Sales Market Share in Volume by Application (2017-2028)
    Figure 36. Global Non-opioid Pain Patch Price by Application (2017-2028) & (USD/K Units)
    Figure 37. United States Non-opioid Pain Patch Market Share by Application in 2022 & 2028
    Figure 38. United States Non-opioid Pain Patch Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 39. United States Non-opioid Pain Patch Sales Market Share in Value by Application (2017-2028)
    Figure 40. United States Non-opioid Pain Patch Sales by Application (2017-2028) & (M Units)
    Figure 41. United States Non-opioid Pain Patch Sales Market Share in Volume by Application (2017-2028)
    Figure 42. United States Non-opioid Pain Patch Price by Application (2017-2028) & (USD/K Units)
    Figure 43. North America Non-opioid Pain Patch Sales in Volume Growth Rate 2017-2028 (M Units)
    Figure 44. North America Non-opioid Pain Patch Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 45. U.S. Non-opioid Pain Patch Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Canada Non-opioid Pain Patch Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Europe Non-opioid Pain Patch Sales in Volume Growth Rate 2017-2028 (M Units)
    Figure 48. Europe Non-opioid Pain Patch Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 49. Germany Non-opioid Pain Patch Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. France Non-opioid Pain Patch Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. U.K. Non-opioid Pain Patch Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Italy Non-opioid Pain Patch Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Russia Non-opioid Pain Patch Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Asia-Pacific Non-opioid Pain Patch Sales in Volume Growth Rate 2017-2028 (M Units)
    Figure 55. Asia-Pacific Non-opioid Pain Patch Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 56. China Non-opioid Pain Patch Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Japan Non-opioid Pain Patch Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. South Korea Non-opioid Pain Patch Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. India Non-opioid Pain Patch Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Australia Non-opioid Pain Patch Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Taiwan Non-opioid Pain Patch Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Indonesia Non-opioid Pain Patch Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Thailand Non-opioid Pain Patch Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Malaysia Non-opioid Pain Patch Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Philippines Non-opioid Pain Patch Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Latin America Non-opioid Pain Patch Sales in Volume Growth Rate 2017-2028 (M Units)
    Figure 67. Latin America Non-opioid Pain Patch Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 68. Mexico Non-opioid Pain Patch Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Brazil Non-opioid Pain Patch Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Argentina Non-opioid Pain Patch Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Middle East & Africa Non-opioid Pain Patch Sales in Volume Growth Rate 2017-2028 (M Units)
    Figure 72. Middle East & Africa Non-opioid Pain Patch Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 73. Turkey Non-opioid Pain Patch Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. Saudi Arabia Non-opioid Pain Patch Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 75. UAE Non-opioid Pain Patch Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 76. Non-opioid Pain Patch Value Chain
    Figure 77. Non-opioid Pain Patch Production Process
    Figure 78. Channels of Distribution
    Figure 79. Distributors Profiles
    Figure 80. Bottom-up and Top-down Approaches for This Report
    Figure 81. Data Triangulation
    Figure 82. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Hisamitsu
Mylan
Johnson & Johnson
Actavis
Lingrui
Teikoku Seiyaku
Sanofi
Novartis
Qizheng
Endo
Huarun 999
GSK
Haw Par
Nichiban
Mentholatum
Laboratoires Genevrier
BLUE-EMU
Frequently Asked Questions
Non-opioid Pain Patch report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Non-opioid Pain Patch report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Non-opioid Pain Patch report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Thin Film Drug

Thin Film Drug market is segmented by region (country), players, by Type and by Application. Play ... Read More

Document Imaging

Document Imaging market is segmented by region (country), players, by Type and by Application. Pl ... Read More